We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSGP icon
226
CoStar Group
CSGP
$13.1B
$388K 0.02%
4,019
-48
-1% -$4.13K
RXRX icon
227
Recursion Pharmaceuticals
RXRX
$1.79B
$386K 0.02%
38,727
-15,367
-28% -$171K
NUVL
228
DELISTED
Nuvalent
NUVL
$386K 0.02%
5,136
-1,662
-24% -$132K
ARQT icon
229
Arcutis Biotherapeutics
ARQT
$2.99B
$385K 0.02%
+38,866
New +$290K
BEAM icon
230
Beam Therapeutics
BEAM
$3.03B
$382K 0.02%
11,547
-6,627
-36% -$206K
NVAX icon
231
Novavax
NVAX
$1.53B
$380K 0.02%
79,514
-7,044
-8% -$32.7K
CLDX icon
232
Celldex Therapeutics
CLDX
$3.07B
$380K 0.02%
9,046
+1,097
+14% +$45K
WB icon
233
Weibo
WB
$1.72B
$377K 0.02%
41,516
-267,620
-87% -$2.43M
BCRX icon
234
BioCryst Pharmaceuticals
BCRX
$2.51B
$377K 0.02%
74,180
+22,863
+45% +$129K
GERN icon
235
Geron
GERN
$970M
$376K 0.02%
113,941
+24,308
+27% +$54.5K
TEL icon
236
TE Connectivity
TEL
$58.7B
$375K 0.02%
2,581
-41
-2% -$5.75K
PHM icon
237
Pultegroup
PHM
$24.5B
$374K 0.02%
+3,104
New +$333K
CRSP icon
238
CRISPR Therapeutics
CRSP
$5.58B
$374K 0.02%
5,491
-3,969
-42% -$284K
KROS icon
239
Keros Therapeutics
KROS
$219M
$374K 0.02%
+5,648
New +$335K
ARWR icon
240
Arrowhead Research
ARWR
$12B
$371K 0.02%
12,956
-6,575
-34% -$210K
ELV icon
241
Elevance Health
ELV
$85.5B
$370K 0.02%
713
+93
+15% +$46.3K
EXC icon
242
Exelon
EXC
$45.3B
$369K 0.02%
9,831
-82
-0.8% -$2.93K
MORF
243
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$367K 0.02%
10,434
-454
-4% -$15.2K
CPRX
244
DELISTED
Catalyst Pharmaceutical
CPRX
$367K 0.02%
23,003
+4,090
+22% +$61.6K
ARDX icon
245
Ardelyx
ARDX
$984M
$364K 0.02%
49,868
-23,717
-32% -$203K
SYK icon
246
Stryker
SYK
$127B
$363K 0.02%
1,014
+57
+6% +$19.2K
MDT icon
247
Medtronic
MDT
$117B
$359K 0.02%
4,124
+507
+14% +$43.3K
VERA icon
248
Vera Therapeutics
VERA
$2.46B
$356K 0.02%
+8,260
New +$294K
PRTA icon
249
Prothena Corp
PRTA
$479M
$355K 0.02%
14,340
+3,244
+29% +$96.5K
AKRO
250
DELISTED
Akero Therapeutics
AKRO
$351K 0.02%
13,899
-10,273
-42% -$247K
8 9
10
11 12

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.